What is a stock summary page? Click here for an overview.
Business Description
Sinopharm Group Co Ltd
NAICS : 325412
ISIN : CNE100000FN7
Share Class Description:
SHTDF: HCompare
Compare
Traded in other countries / regions
01099.Hong KongSHTDY.USAX2S.Germany IPO Date
2009-11-16Description
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.71 | |||||
| Equity-to-Asset | 0.2 | |||||
| Debt-to-Equity | 0.97 | |||||
| Debt-to-EBITDA | 4.54 | |||||
| Interest Coverage | 6.98 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.35 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | -3 | |||||
| 3-Year EPS without NRI Growth Rate | 1.7 | |||||
| 3-Year FCF Growth Rate | 14.6 | |||||
| 3-Year Book Growth Rate | 6.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.15 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.37 | |||||
| 9-Day RSI | 3.64 | |||||
| 14-Day RSI | 8.88 | |||||
| 3-1 Month Momentum % | -1.47 | |||||
| 6-1 Month Momentum % | 24.54 | |||||
| 12-1 Month Momentum % | -6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.39 | |||||
| Quick Ratio | 1.14 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 43.34 | |||||
| Days Sales Outstanding | 123.75 | |||||
| Days Payable | 102.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.71 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| 3-Year Dividend Growth Rate | 8.9 | |||||
| Forward Dividend Yield % | 4.36 | |||||
| 5-Year Yield-on-Cost % | 8.2 | |||||
| Shareholder Yield % | -1.76 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7.57 | |||||
| Operating Margin % | 3.27 | |||||
| Net Margin % | 1.21 | |||||
| FCF Margin % | 3.03 | |||||
| ROE % | 9.18 | |||||
| ROA % | 1.74 | |||||
| ROIC % | 7.27 | |||||
| 3-Year ROIIC % | 1.84 | |||||
| ROC (Joel Greenblatt) % | 16.49 | |||||
| ROCE % | 11.58 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.65 | |||||
| Forward PE Ratio | 6.07 | |||||
| PE Ratio without NRI | 5.41 | |||||
| Shiller PE Ratio | 7.43 | |||||
| Price-to-Owner-Earnings | 6.28 | |||||
| PEG Ratio | 1.02 | |||||
| PS Ratio | 0.09 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.77 | |||||
| Price-to-Free-Cash-Flow | 3.04 | |||||
| Price-to-Operating-Cash-Flow | 2.63 | |||||
| EV-to-EBIT | 7.36 | |||||
| EV-to-Forward-EBIT | 4.27 | |||||
| EV-to-EBITDA | 7.36 | |||||
| EV-to-Forward-EBITDA | 3.8 | |||||
| EV-to-Revenue | 0.21 | |||||
| EV-to-Forward-Revenue | 0.13 | |||||
| EV-to-FCF | 6.94 | |||||
| Price-to-GF-Value | 0.86 | |||||
| Price-to-Projected-FCF | 0.29 | |||||
| Price-to-DCF (Earnings Based) | 0.25 | |||||
| Price-to-DCF (FCF Based) | 0.16 | |||||
| Price-to-Median-PS-Value | 0.36 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.97 | |||||
| Price-to-Graham-Number | 0.43 | |||||
| Price-to-Net-Current-Asset-Value | 1.62 | |||||
| Earnings Yield (Greenblatt) % | 13.59 | |||||
| FCF Yield % | 32.89 | |||||
| Forward Rate of Return (Yacktman) % | 27.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SHTDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinopharm Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 80,426.909 | ||
| EPS (TTM) ($) | 0.311 | ||
| Beta | 0.04 | ||
| 3-Year Sharpe Ratio | 0.06 | ||
| 3-Year Sortino Ratio | 0.1 | ||
| Volatility % | 42.94 | ||
| 14-Day RSI | 8.88 | ||
| 14-Day ATR ($) | 0.024554 | ||
| 20-Day SMA ($) | 2.438325 | ||
| 12-1 Month Momentum % | -6 | ||
| 52-Week Range ($) | 1.97 - 2.94 | ||
| Shares Outstanding (Mil) | 3,120.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinopharm Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinopharm Group Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinopharm Group Co Ltd Frequently Asked Questions
What is Sinopharm Group Co Ltd(SHTDF)'s stock price today?
The current price of SHTDF is $2.15. The 52 week high of SHTDF is $2.94 and 52 week low is $1.97.
When is next earnings date of Sinopharm Group Co Ltd(SHTDF)?
The next earnings date of Sinopharm Group Co Ltd(SHTDF) is 2025-08-26 Est..
Does Sinopharm Group Co Ltd(SHTDF) pay dividends? If so, how much?
The Dividend Yield %  of Sinopharm Group Co Ltd(SHTDF) is 5.71% (As of Today), Highest Dividend Payout Ratio of Sinopharm Group Co Ltd(SHTDF) was 0.28. The lowest was 0.21. And the median was 0.24. The  Forward Dividend Yield % of Sinopharm Group Co Ltd(SHTDF) is 4.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers